Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on the Safety, Effectiveness, and Blood Movement of Bimekizumab in Adolescents with Moderate to Severe Plaque Psoriasis
GermanyStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
BulgariaStudy on the Safety and Effectiveness of ADX-914 for Patients with Moderate to Severe Atopic Dermatitis
PolandStudy on the Safety and Effectiveness of Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo
BulgariaStudy on the Effects of EryDex (Dexamethasone Sodium Phosphate) for Children Aged 6-9 with Ataxia Telangiectasia
BelgiumLong-term safety study of garadacimab (CSL312) for prevention of hereditary angioedema attacks
CzechiaStudy Comparing Human Normal Immunoglobulin and Placebo for Children with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)
ItalyStudy on the Safety and Effectiveness of Apraglutide for Patients with Steroid-Resistant Gastrointestinal Acute Graft Versus Host Disease
GermanyStudy on Latent Autoimmune Diabetes in Adults (LADA) Patients: Evaluating Diabetes Status 3 Years After Treatment with Glutamate Decarboxylase 2
NorwayStudy on Ublituximab and Drug Combination for Patients with Myasthenia Gravis or Relapsing Multiple Sclerosis
PolandLong-term Study on the Safety and Efficacy of Efgartigimod in Adults with Primary Immune Thrombocytopenia
CzechiaStudy on the Effects of Inebilizumab for Adults with Myasthenia Gravis
FranceThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
